212 related articles for article (PubMed ID: 23220009)
1. Calcium, cancer and killing: the role of calcium in killing cancer cells by cytotoxic T lymphocytes and natural killer cells.
Schwarz EC; Qu B; Hoth M
Biochim Biophys Acta; 2013 Jul; 1833(7):1603-11. PubMed ID: 23220009
[TBL] [Abstract][Full Text] [Related]
2. A calcium optimum for cytotoxic T lymphocyte and natural killer cell cytotoxicity.
Zhou X; Friedmann KS; Lyrmann H; Zhou Y; Schoppmeyer R; Knörck A; Mang S; Hoxha C; Angenendt A; Backes CS; Mangerich C; Zhao R; Cappello S; Schwär G; Hässig C; Neef M; Bufe B; Zufall F; Kruse K; Niemeyer BA; Lis A; Qu B; Kummerow C; Schwarz EC; Hoth M
J Physiol; 2018 Jul; 596(14):2681-2698. PubMed ID: 29368348
[TBL] [Abstract][Full Text] [Related]
3. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
4. A calcium optimum for cytotoxic T lymphocyte and natural killer cell cytotoxicity.
Kaschek L; Zöphel S; Knörck A; Hoth M
Semin Cell Dev Biol; 2021 Jul; 115():10-18. PubMed ID: 33358089
[TBL] [Abstract][Full Text] [Related]
5. Identification of molecular candidates which regulate calcium-dependent CD8
Zöphel S; Schäfer G; Nazarieh M; Konetzki V; Hoxha C; Meese E; Hoth M; Helms V; Hamed M; Schwarz EC
Mol Immunol; 2023 May; 157():202-213. PubMed ID: 37075611
[TBL] [Abstract][Full Text] [Related]
6. Death ligands and granulysin: mechanisms of tumor cell death induction and therapeutic opportunities.
Martinez-Lostao L; de Miguel D; Al-Wasaby S; Gallego-Lleyda A; Anel A
Immunotherapy; 2015; 7(8):883-2. PubMed ID: 26314314
[TBL] [Abstract][Full Text] [Related]
7. Differences in target cell DNA fragmentation induced by mouse cytotoxic T lymphocytes and natural killer cells.
Duke RC; Cohen JJ; Chervenak R
J Immunol; 1986 Sep; 137(5):1442-7. PubMed ID: 2943792
[TBL] [Abstract][Full Text] [Related]
8. Killer dendritic cells: IKDC and the others.
Bonmort M; Dalod M; Mignot G; Ullrich E; Chaput N; Zitvogel L
Curr Opin Immunol; 2008 Oct; 20(5):558-65. PubMed ID: 18554881
[TBL] [Abstract][Full Text] [Related]
9. Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors.
Jiang S; Persechini PM; Perussia B; Young JD
J Immunol; 1989 Sep; 143(5):1453-60. PubMed ID: 2503557
[TBL] [Abstract][Full Text] [Related]
10. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
11. Prevention of CTL and NK cell-mediated cytotoxicity by microencapsulation.
Soon-Shiong P; Lu ZN; Grewal I; Lanza R; Clark W
Horm Metab Res Suppl; 1990; 25():215-9. PubMed ID: 2088973
[TBL] [Abstract][Full Text] [Related]
12. Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen.
Brooks CG; Holscher M; Urdal D
J Immunol; 1985 Aug; 135(2):1145-52. PubMed ID: 2409140
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of cytolytic T lymphocytes (CTL) and natural killer (NK) cells in head and neck cancer.
Whiteside TL; Chikamatsu K; Nagashima S; Okada K
Anticancer Res; 1996; 16(4C):2357-64. PubMed ID: 8816835
[TBL] [Abstract][Full Text] [Related]
14. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
Suzuki R; Suzuki S; Ebina N; Kumagai K
J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
[TBL] [Abstract][Full Text] [Related]
15. Neem leaf glycoprotein induces perforin-mediated tumor cell killing by T and NK cells through differential regulation of IFNgamma signaling.
Bose A; Chakraborty K; Sarkar K; Goswami S; Chakraborty T; Pal S; Baral R
J Immunother; 2009 Jan; 32(1):42-53. PubMed ID: 19307993
[TBL] [Abstract][Full Text] [Related]
16. Leu-Leu-OMe sensitivity of human activated killer cells: delineation of a distinct class of cytotoxic T lymphocytes capable of lysing tumor targets.
Thiele DL; Lipsky PE
J Immunol; 1986 Aug; 137(4):1399-406. PubMed ID: 3488348
[TBL] [Abstract][Full Text] [Related]
17. Degradation of specificity in cytolytic T lymphocyte clones. The separate YAC-1-type (NK-like) and P815-type broad specificity killing patterns are both restricted to the larger cells within a clone but may be expressed independently in clones from different mouse strains.
Shortman K; Wilson A
J Immunol; 1986 Aug; 137(3):798-804. PubMed ID: 2424983
[TBL] [Abstract][Full Text] [Related]
18. Involvement of nonclassical MHC class Ib molecules in heat shock protein-mediated anti-tumor responses.
Goyos A; Guselnikov S; Chida AS; Sniderhan LF; Maggirwar SB; Nedelkovska H; Robert J
Eur J Immunol; 2007 Jun; 37(6):1494-501. PubMed ID: 17492621
[TBL] [Abstract][Full Text] [Related]
19. Lysis of myotubes by alloreactive cytotoxic T cells and natural killer cells. Relevance to myoblast transplantation.
Hohlfeld R; Engel AG
J Clin Invest; 1990 Jul; 86(1):370-4. PubMed ID: 2365826
[TBL] [Abstract][Full Text] [Related]
20. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
Arancia G; Malorni W; Donelli G
Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
